Conference Coverage: ASH 2022 – Focus on Leukemia

Expert perspectives on the latest therapeutic developments, treatment approaches, and implications for clinical decision-making regarding leukemia.

December 14, 2022

Faculty Chair

Elias Jabbour, MD

The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Faculty Members

Rami Komrokji, MD
H. Lee Moffitt Cancer Center, Tampa, FL, USA

Valeria Santini, MD
University of Florence, Italy

Naval Daver, MD
The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Charles Craddock, CBE, FRCP (UK), FRCPath, DPhil, FMedSci
Queen Elizabeth Hospital, Birmingham, UK

Gail J. Roboz, MD
Weill Cornell Medicine, New York, NY, USA

Amir Fathi, MD
Massachusetts General Hospital, Boston, MA, USA

Josep-Maria Ribera, MD, PhD
Hospital Universitari Germans Trias i Pujol, Barcelona, Spain

Jae Park, MD
Memorial Sloan Kettering Cancer Center, New York, NY, USA

Agenda

Download the meeting agenda

View Agenda

REPORT SNAPSHOT

  • New Developments in Myelodysplastic Syndromes (MDS)
  • Advances in Acute Myeloid Leukemia (AML): Newly Diagnosed
  • Advances in AML: Relapsed/Refractory (R/R)
  • Advances in Acute Lymphoblastic Leukemia (ALL): Newly Diagnosed
  • Advances in ALL: Relapsed/Refractory

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.